Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents

Diabetes

Volumn 51, Issue 12, 2002, Pages 3408-3411

  Ikezaki, Ayako ^a   Hosoda, Hiroshi ^b,c   Ito, Keiko ^a   Iwama, Saika ^a   Miura, Naoko ^a   Matsuoka, Hisafumi ^a   Kondo, Chisato ^d   Kojima, Masayasu ^e   Kangawa, Kenji ^b,c   Sugihara, Shigetaka ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; IMMUNOREACTIVE INSULIN; LEPTIN;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FOOD INTAKE; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; MALE; OBESITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUBCUTANEOUS FAT; WEIGHT GAIN;

EID: 0036896934     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.12.3408     Document Type: Article

References (20)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660, 1999
2. Tschöp M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 407:908-913, 2000
3. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S: A role for ghrelin in the central regulation of feeding. Nature 409:194-198, 2001
4. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328, 2000
5. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992-5995, 2001
6. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K: Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50:227-232, 2001
7. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML: Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709, 2001
8. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S: Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240-244, 2002
9. Ikezaki A, Miura N, Kikuoka N, Kim HS, Matsuoka H, Ito K, Murata M, Sugihara S: Clinical characteristics of obese Japanese children with acanthosis nigricans. Clin Pediatr Endocrinol 10:47-52, 2001
10. Hamsten A, Wiman B, Faire de U, Blomback M: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563, 1985
11. Juhan-Vague I, Alessi MC, Morange PE: Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med 32 (Suppl. 1):78-84, 2000
12. Shimomura I, Funabashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity. Nat Med 2:800-803, 1996
13. Iwata K, Satou Y, Iwata F, Hara M, Fuchigami S, Kin H, Fuchigami T, Okada T, Harada K, Ohkuni M: Assessment of body composition measured by bioelectrical impedance in children. Acta Paediatrica Japonica 35:369-372, 1993
14. Hosoda H, Kojima M, Matsuo H, Kangawa K: Ghrelin and des-acyl ghrelin: Two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 279:909-913, 2000
15. Declerck PJ, Alessi M-C, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D: Measurement of plasminogen activator inhibitor 1 (PAI-1) in biological fluids, with a murine monoclonal antibody based enzyme-linked immunosorbent assay. Blood 71:220-225, 1988
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
17. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410, 2000
18. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lahone R, Ranaganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161, 1995
19. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TK, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
20. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719, 2001